Key facts
- Diagnostica Nobiliore’s last known valuation is $8.4M (May 2025).
- Notable investors include Lazio Innova.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Diagnostica Nobiliore
- ·The full record, as it builds
Funding rounds
No funding rounds for Diagnostica Nobiliore are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Diagnostica Nobiliore
Provider of diagnostic imaging and radiology services intended to support medical professionals and patients with clinical examinations in Rome, Italy. The company's diagnostic centre offers advanced imaging services, including high-field MRI with an anti-claustrophobia kit, CT scans with and without contrast, MOC/Dexa bone density tests, and other radiology exams with experienced radiologists on-site and appointments organised for timely reports, enabling patients and physicians access to reliable clinical diagnostics for a wide range of health conditions.
- Sector
- Healthcare
- HQ
- Rome, Italy
- Founded
- 1983
- Employees
- 20
- Website
- nobiliore.it/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Diagnostica Nobiliore doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Diagnostica Nobiliore shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Diagnostica Nobiliore in its N-PORT filings yet. We sweep new filings monthly.